Cornercap Investment Counsel Inc. Reduces Stock Position in HCA Healthcare, Inc. (NYSE:HCA)

Cornercap Investment Counsel Inc. lessened its holdings in HCA Healthcare, Inc. (NYSE:HCA) by 35.8% during the 3rd quarter, HoldingsChannel.com reports. The institutional investor owned 4,991 shares of the company’s stock after selling 2,786 shares during the quarter. HCA Healthcare makes up approximately 0.6% of Cornercap Investment Counsel Inc.’s holdings, making the stock its 11th largest position. Cornercap Investment Counsel Inc.’s holdings in HCA Healthcare were worth $2,028,000 at the end of the most recent quarter.

Several other large investors also recently bought and sold shares of the stock. Bangor Savings Bank boosted its stake in shares of HCA Healthcare by 112.5% during the second quarter. Bangor Savings Bank now owns 85 shares of the company’s stock worth $27,000 after buying an additional 45 shares during the period. MFA Wealth Advisors LLC purchased a new position in shares of HCA Healthcare during the 2nd quarter worth approximately $27,000. Unique Wealth Strategies LLC acquired a new stake in HCA Healthcare during the second quarter worth approximately $28,000. GPS Wealth Strategies Group LLC boosted its holdings in shares of HCA Healthcare by 284.0% in the 2nd quarter. GPS Wealth Strategies Group LLC now owns 96 shares of the company’s stock valued at $31,000 after purchasing an additional 71 shares during the last quarter. Finally, Benjamin F. Edwards & Company Inc. acquired a new position in shares of HCA Healthcare during the 2nd quarter valued at $33,000. Institutional investors and hedge funds own 62.73% of the company’s stock.

HCA Healthcare Stock Performance

Shares of HCA opened at $345.36 on Friday. HCA Healthcare, Inc. has a 12 month low of $237.57 and a 12 month high of $417.14. The company’s fifty day moving average is $387.05 and its 200-day moving average is $357.11. The company has a quick ratio of 1.00, a current ratio of 1.12 and a debt-to-equity ratio of 48.71. The firm has a market cap of $87.48 billion, a price-to-earnings ratio of 15.51, a price-to-earnings-growth ratio of 1.34 and a beta of 1.68.

HCA Healthcare Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, December 27th. Stockholders of record on Friday, December 13th will be issued a dividend of $0.66 per share. This represents a $2.64 dividend on an annualized basis and a dividend yield of 0.76%. The ex-dividend date is Friday, December 13th. HCA Healthcare’s payout ratio is 11.85%.

Analyst Ratings Changes

Several equities research analysts recently issued reports on the stock. Barclays dropped their price target on shares of HCA Healthcare from $396.00 to $392.00 and set an “overweight” rating on the stock in a research note on Friday, November 8th. Truist Financial boosted their target price on shares of HCA Healthcare from $390.00 to $430.00 and gave the company a “buy” rating in a research note on Monday, August 19th. Royal Bank of Canada increased their price objective on shares of HCA Healthcare from $378.00 to $405.00 and gave the company an “outperform” rating in a report on Friday, August 23rd. Leerink Partners increased their price objective on shares of HCA Healthcare from $367.00 to $396.00 and gave the company an “outperform” rating in a report on Wednesday, July 24th. Finally, KeyCorp decreased their price objective on shares of HCA Healthcare from $475.00 to $420.00 and set an “overweight” rating for the company in a report on Monday, October 28th. Five research analysts have rated the stock with a hold rating, thirteen have issued a buy rating and two have given a strong buy rating to the stock. According to MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average price target of $385.00.

Insider Transactions at HCA Healthcare

In other HCA Healthcare news, SVP Phillip G. Billington sold 3,897 shares of the business’s stock in a transaction dated Thursday, November 14th. The shares were sold at an average price of $350.00, for a total value of $1,363,950.00. Following the completion of the transaction, the senior vice president now directly owns 52,702 shares of the company’s stock, valued at approximately $18,445,700. The trade was a 6.89 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, insider Erol R. Akdamar sold 2,900 shares of the business’s stock in a transaction that occurred on Thursday, November 14th. The shares were sold at an average price of $353.00, for a total transaction of $1,023,700.00. Following the transaction, the insider now owns 6,843 shares of the company’s stock, valued at approximately $2,415,579. This represents a 29.76 % decrease in their position. The disclosure for this sale can be found here. In the last three months, insiders sold 15,155 shares of company stock valued at $5,608,990. Company insiders own 1.60% of the company’s stock.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.